We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+8.35%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$116B
AUM Growth
+$12.3B
Cap. Flow
-$2.57B
Cap. Flow %
-2.21%
Top 10 Hldgs %
9.91%
Holding
5,208
New
1,193
Increased
1,491
Reduced
1,580
Closed
489

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$672M
2
MRK icon
Merck
MRK
+$476M
3
META icon
Meta Platforms (Facebook)
META
+$392M
4
MCD icon
McDonald's
MCD
+$372M
5
WFC icon
Wells Fargo
WFC
+$357M

Sector Composition

Rank Sector Weight
1 Technology 15.62%
2 Consumer Discretionary 9.84%
3 Healthcare 7.45%
4 Communication Services 7.19%
5 Financials 5.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRGA
4201
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$246K ﹤0.01%
5,895
-1,611
-21% -$82.5K
NTRS icon
4202
Northern Trust
NTRS
$22.2B
$245K ﹤0.01%
+2,119
New +$243K
BTMD icon
4203
Biote Corp
BTMD
$69.2M
$243K ﹤0.01%
+25,000
New +$245K
TSHA icon
4204
Taysha Gene Therapies
TSHA
$1.59B
$243K ﹤0.01%
+11,448
New +$264K
VIA
4205
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
$243K ﹤0.01%
4,288
-385
-8% -$20.6K
ALSK
4206
DELISTED
Alaska Communications Systems
ALSK
$243K ﹤0.01%
+72,955
New +$242K
BRBR icon
4207
BellRing Brands
BRBR
$1.51B
$242K ﹤0.01%
+7,721
New +$211K
MRVL icon
4208
Marvell Technology
MRVL
$174B
$242K ﹤0.01%
4,145
-41,853
-91% -$2.05M
IBER
4209
DELISTED
Ibere Pharmaceuticals
IBER
$242K ﹤0.01%
+25,000
New +$243K
PCPC.WS
4210
DELISTED
Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75
PCPC.WS
$242K ﹤0.01%
112,500
ASYS icon
4211
Amtech Systems
ASYS
$278M
$241K ﹤0.01%
+24,958
New +$256K
CUZ icon
4212
Cousins Properties
CUZ
$5.29B
$241K ﹤0.01%
+6,551
New +$241K
DLR icon
4213
Digital Realty Trust
DLR
$73.7B
$240K ﹤0.01%
+1,595
New +$241K
FIBK icon
4214
First Interstate BancSystem
FIBK
$3.7B
$240K ﹤0.01%
5,731
-12,300
-68% -$567K
STOK icon
4215
Stoke Therapeutics
STOK
$1.82B
$240K ﹤0.01%
7,143
-4,714
-40% -$167K
TGS icon
4216
Transportadora de Gas del Sur
TGS
$4.59B
$240K ﹤0.01%
51,743
+31,314
+153% +$149K
IMPL
4217
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
$240K ﹤0.01%
+27,142
New +$324K
NPK icon
4218
National Presto Industries
NPK
$891M
$239K ﹤0.01%
2,349
-216
-8% -$22.3K
QNCX icon
4219
Quince Therapeutics
QNCX
$17.5M
$239K ﹤0.01%
+23
New +$193K
SNA icon
4220
Snap-on
SNA
$20.9B
$239K ﹤0.01%
+1,070
New +$256K
TTGT icon
4221
TechTarget
TTGT
$246M
$239K ﹤0.01%
3,088
-2,721
-47% -$195K
MLTX icon
4222
MoonLake Immunotherapeutics
MLTX
$1.59B
$238K ﹤0.01%
+23,013
New +$234K
WPC icon
4223
W.P. Carey
WPC
$17.1B
$238K ﹤0.01%
3,257
-424,234
-99% -$31.1M
VNET
4224
VNET Group
VNET
$2.05B
$237K ﹤0.01%
10,323
-19,412
-65% -$494K
AGNC icon
4225
AGNC Investment
AGNC
$12.3B
$236K ﹤0.01%
13,971
-27,668
-66% -$492K

Similar funds

D.E. Shaw & Co's Q2 2021 Portfolio in Review

As of Q2 2021, D.E. Shaw & Co held 5,208 positions worth $116B, up 12% from $104B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

D.E. Shaw & Co's Q2 2021 filing shows 1,193 new, 1,491 increased, 1,580 reduced and 489 closed positions. Its largest new stake was Weatherford International: 4,894,906 shares worth $89.1M. The largest sale was Microsoft, an estimated $672M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • D.E. Shaw & Co's largest Q2 2021 buy was Weatherford International: 4,894,906 shares worth $89.1M.
  • D.E. Shaw & Co added most to Just Eat Takeaway.com N.V. American Depositary Shares in Q2 2021, an estimated $700M increase.
  • D.E. Shaw & Co's biggest Q2 2021 reduction was Microsoft, cutting an estimated $672M.
  • D.E. Shaw & Co fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $131M.
  • D.E. Shaw & Co's ten largest holdings make up 9.9% of its $116B portfolio in Q2 2021.
  • D.E. Shaw & Co opened 1,193 new positions and closed 489 in Q2 2021.
  • D.E. Shaw & Co's portfolio value rose 12% quarter-over-quarter to $116B.

Based on D.E. Shaw & Co's 13F filing for Q2 2021, filed 16 Aug 2021.